Search Results

Ionis Pharmaceuticals SWOT Analysis.

Subjects: PHARMACEUTICAL industry; SWOT analysisCARLSBAD (Calif.)IONIS Pharmaceuticals Inc.

• Source: Ionis Pharmaceuticals SWOT Analysis; 1/29/2016, p1-8, 8p

Record details

Isis Pharmaceuticals, Inc. SWOT Analysis.

Subjects: PHARMACEUTICAL industry; SWOT analysisCARLSBAD (Calif.)IONIS Pharmaceuticals Inc.

• Source: Isis Pharmaceuticals, Inc. SWOT Analysis; Jan2016, Vol. 1 Issue 1, p1-9, 9p

Record details

Isis Pharmaceuticals, Inc. SWOT Analysis.

Subjects: PHARMACEUTICAL industry; SWOT analysisCARLSBAD (Calif.)IONIS Pharmaceuticals Inc.

• Source: Isis Pharmaceuticals, Inc. SWOT Analysis; 12/31/2015, Vol. 1 Issue 1, p1-9, 9p

Record details

Isis Pharmaceuticals, Inc. SWOT Analysis.

Subjects: PHARMACEUTICAL industry; SWOT analysisCARLSBAD (Calif.)IONIS Pharmaceuticals Inc.

• Source: Isis Pharmaceuticals, Inc. SWOT Analysis; 12/1/2014, p1-9, 9p

Record details

Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review.

• Source: Evidence Report/Technology Assessment; Aug2016, Issue 223, p1-290, 1252p

Record details

VI. Drug Therapy.

• Source: Current Clinical Practice Guidelines & Reports; 2002, pVI1-VI23, 23p, 1 Diagram, 11 Charts

Record details

VII. Management of Specific Dyslipidemias.

• Source: Current Clinical Practice Guidelines & Reports; 2002, pVII1-VII17, 17p, 10 Charts

Record details

References.

• Source: Current Clinical Practice Guidelines & Reports; 2002, p1-49, 49p

Record details

II. Rationale for Intervention.

• Source: Current Clinical Practice Guidelines & Reports; 2002, pII1-II61, 61p, 31 Charts, 3 Graphs

Record details